Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 8Head & Neck 6Thoracic 5Sarcoma 4Gynecologic 4Breast 3Genitourinary 2Dermatologic 2CNS 2Tumor-Agnostic 1Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1Endocrine 1

Conditions

Prolactinoma 1Pituitary ACTH Hypersecretion 1Gigantism 1Congenital Abnormalities 1Combined Pituitary Hormone Deficiency 1Carcinogenesis 1Acromegaly 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tissue Banks × Endocrine × Clear all
NCT00001595 2026-05-22

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

National Institutes of Health Clinical Center (CC)

Recruiting
2,000 enrolled
Endocrine

Combined Pituitary Hormone Deficiency, Congenital Abnormalities, Acromegaly, Gigantism, Prolactinoma, Pituitary ACTH Hypersecretion, Carcinogenesis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡